File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Chemotherapy at end-of-life: an integration of oncology and palliative team

TitleChemotherapy at end-of-life: an integration of oncology and palliative team
Authors
Chan, WLWLam, KOSiu, WKSYuen, KK
KeywordsChemotherapy
Palliative care
Terminal care
Communication
Issue Date2016
PublisherSpringer Verlag. The Journal's web site is located at http://link.springer.de/link/service/journals/00520/index.htm
Citation
Supportive Care in Cancer, 2016, v. 24 n. 3, p. 1421-1427 How to Cite?
DOI: http://dx.doi.org/10.1007/s00520-015-3031-z
AbstractPalliative chemotherapy is increasingly used in cancer patients near end of life. With the development of newer anticancer agents which have less side effects and higher expected efficacy, the decision on palliative chemotherapy in patients near end of life is complex. This article illustrates how oncologist and palliative care physicians can work together effectively. This article also gives an overview about the risks of palliative chemotherapy near end of life, patients’ and physicians’ perspectives in choosing the aggressive treatment and describes what an oncologist should do when facing this challenging situation.
Persistent Identifierhttp://hdl.handle.net/10722/229159
ISSN
0941-4355
2021 Impact Factor: 3.359
2020 SCImago Journal Rankings: 1.133
ISI Accession Number ID
WOS:000369010000046

 

DC FieldValueLanguage
dc.contributor.authorChan, WLW-
dc.contributor.authorLam, KO-
dc.contributor.authorSiu, WKS-
dc.contributor.authorYuen, KK-
dc.date.accessioned2016-08-23T14:09:21Z-
dc.date.available2016-08-23T14:09:21Z-
dc.date.issued2016-
dc.identifier.citationSupportive Care in Cancer, 2016, v. 24 n. 3, p. 1421-1427-
dc.identifier.issn0941-4355-
dc.identifier.urihttp://hdl.handle.net/10722/229159-
dc.description.abstractPalliative chemotherapy is increasingly used in cancer patients near end of life. With the development of newer anticancer agents which have less side effects and higher expected efficacy, the decision on palliative chemotherapy in patients near end of life is complex. This article illustrates how oncologist and palliative care physicians can work together effectively. This article also gives an overview about the risks of palliative chemotherapy near end of life, patients’ and physicians’ perspectives in choosing the aggressive treatment and describes what an oncologist should do when facing this challenging situation.-
dc.languageeng-
dc.publisherSpringer Verlag. The Journal's web site is located at http://link.springer.de/link/service/journals/00520/index.htm-
dc.relation.ispartofSupportive Care in Cancer-
dc.rightsThe final publication is available at Springer via http://dx.doi.org/10.1007/s00520-015-3031-z-
dc.subjectChemotherapy-
dc.subjectPalliative care-
dc.subjectTerminal care-
dc.subjectCommunication-
dc.titleChemotherapy at end-of-life: an integration of oncology and palliative team-
dc.typeArticle-
dc.identifier.emailChan, WLW: winglok@hku.hk-
dc.identifier.emailLam, KO: lamkaon@hku.hk-
dc.identifier.emailSiu, WKS: siuwks@hkucc.hku.hk-
dc.identifier.emailYuen, KK: yuenkk1@hku.hk-
dc.identifier.authorityChan, WLW=rp02541-
dc.identifier.authorityLam, KO=rp01501-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1007/s00520-015-3031-z-
dc.identifier.pmid26604192-
dc.identifier.scopuseid_2-s2.0-84955667201-
dc.identifier.hkuros260818-
dc.identifier.volume24-
dc.identifier.issue3-
dc.identifier.spage1421-
dc.identifier.epage1427-
dc.identifier.isiWOS:000369010000046-
dc.publisher.placeGermany-
dc.identifier.issnl0941-4355-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats